SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $235,100 | +12.1% | 5,000 | 0.0% | 0.06% | -12.2% |
| Q1 2023 | $209,800 | -5.5% | 5,000 | 0.0% | 0.07% | +2.8% |
| Q3 2021 | $222,000 | -40.6% | 5,000 | 0.0% | 0.07% | -32.7% |
| Q1 2021 | $374,000 | -13.6% | 5,000 | 0.0% | 0.11% | -15.1% |
| Q4 2020 | $433,000 | +41.5% | 5,000 | 0.0% | 0.13% | +28.6% |
| Q3 2020 | $306,000 | +47.1% | 5,000 | 0.0% | 0.10% | +32.4% |
| Q2 2020 | $208,000 | – | 5,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |